Welcome to Shashwat Pharma
“Shashwat Pharma” and our skilled staff produce and supply a broad variety of pharmaceutical finished formulations, such as tablets, capsules, oral syrups and suspensions, dry syrups, injections, and prefilled syringes.
We provide medication for a variety of therapeutic areas, including oncology, analgesic, antipyretic, anti-inflammatory, anti-psychotic, anti-depressant, anti-cancer, hyperacidity, anti-ulcer, anti-vomiting, anti-helminthic, anti-malarial, anti-viral, and anti-allergic conditions. One of the top producers and distributors of biosimilars and generic cancer drugs is Shashwat Pharma.
Research and Development (R&D)
The Company’s R&D strengths are in developing intellectual property in non-infringing processes and resolving complex chemistry challenges. Shashwat Pharma is in the process of developing new drug delivery systems, new dosage formulations, and applying new technology for better processes.
The Centre meets cGLP requirements, and is focused on the areas of organic synthesis, analytical research, dosage form development, pharmacology, bio-equivalence studies and drug delivery systems.
The instrumentation and analytical knowledge base at the Centre facilitate:
- Complete impurity profiling in all products developed.
- Development of analytical methods and specifications from raw materials, to non-compendial finished products.
- In-house synthesis of reagents for analysing organolithiums and noble metals.
- Accelerated and real-time stability studies.
This reflects the Company’s commitment towards developing innovative technologies and creating a knowledge base in chemical synthesis, high quality generic formulations and development of drug delivery systems.
Around the world, millions of people depend on Shashwat Pharma’s oncology products for their medical needs. Shashwat Pharma is ready to work with organizations around the world on the development, registration, and delivery of oncology products to provide a steady supply of safe pharmaceuticals.
We are also the leading producer and seller of anti-HIV/anti-retroviral drugs in India. Customers in other countries may have to decide between contract manufacturing and third-party manufacture.
Among the many Latin American nations that we serve as clients are Bolivia, Ecuador, Chile, Venezuela, Brazil, Colombia, Trinidad & Tobago, and El Salvador. We also have clientele throughout the Commonwealth of Independent States, which includes, among other countries, Uzbekistan, Kyrgyzstan, and Tajikistan.
In addition to our oncology facility, other, specialized facilities are used to create our general, cephalosporin, and beta-lactam range of final formulations. Soft gel capsules, pills, nasal sprays, ointments, creams, jelly, pre-filled syringes, lotions, and intravenous infusions are among the products we offer.
Our Achievements and Capabilities
The Centre is capable of developing, scaling up and commercializing various dosage forms spread across tablets, capsules, soft gels, oral liquids, injectables (solutions, suspensions, lyophilized, etc.), and ophthalmic (three piece and BFS) and nasal delivery systems.The focus is to develop products for the US and EU followed by other international markets, including specialized markets like Japan.
We can develop complex in-vitro analytical as well as bio- analytical methods for various molecules including extremely potent drug combinations to support the formulation development team.
The R&D Centre has developed products and filed more than 200 ANDA’s, around 124 EU Dossiers for products and hundreds of Dossiers in other countries including Brazil, South Africa, Australia and China.The product range covers various pharmacological categories with special focus on anti-retroviral, anti-biotic, CNS and CVS drugs.